Provided by Tiger Trade Technology Pte. Ltd.

Trevena, Inc.

0.0005
0.0000
Volume:- -
Turnover:- -
Market Cap:431.90
PE:0.00
High:0.0005
Open:0.0005
Low:0.0005
Close:0.0005
52wk High:1.50
52wk Low:0.0003
Shares:863.80K
Float Shares:863.80K
Volume Ratio:0.02
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-42.7197
EPS(LYR):-79.0911
ROE:-1014.58%
ROA:-62.39%
PB:-0.00
PE(LYR):0.00

Loading ...

Company Profile

Company Name:
Trevena, Inc.
Exchange:
EXPERT
Establishment Date:
2007
Employees:
- -
Office Location:
955 Chesterbrook Boulevard,Suite 110,Chesterbrook,Pennsylvania,United States
Zip Code:
19087
Fax:
- -
Introduction:
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.